A review on recent advances in drugs for lung cancer treatment

A review on recent advances in drugs for lung cancer treatment

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Bibliografiset tiedot
Päätekijä:	Noor, Fouzia
Muut tekijät:	Akter, Raushanara
Aineistotyyppi:	Opinnäyte
Kieli:	English
Julkaistu:	Brac University 2024
Aiheet:	Lung cancer Recent advances Drugs Resistance Mechanism of action Lung cancer > Treatment
Linkit:	http://hdl.handle.net/10361/22049

Samankaltaisia teoksia

Potential of liposomes for the treatment of lung cancer- a review
Tekijä: Mim, Shanzida
Julkaistu: (2023)

A review on targeted therapies for lung cancer
Tekijä: Ashraf, Anushey
Julkaistu: (2023)

Molecules associated with the development of lung cancer
Tekijä: Rahman, Adree, et al.
Julkaistu: (2023)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
Tekijä: Rahman, Tasnim
Julkaistu: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
Tekijä: Jeba, Joynob
Julkaistu: (2017)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
Tekijä: Razna, Amrin Islam
Julkaistu: (2019)

Immunotherapy in the Management of Lung Cancer
Tekijä: Tasnim, Humayra
Julkaistu: (2022)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
Tekijä: Pial, Sazia Afrin
Julkaistu: (2018)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
Tekijä: Das, Reshita
Julkaistu: (2024)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
Tekijä: Tania, Umme
Julkaistu: (2023)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
Tekijä: Zangmo, Thinley
Julkaistu: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
Tekijä: Hoque, Ismoth Ara
Julkaistu: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Tekijä: Flora, Sanzida Alam
Julkaistu: (2024)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
Tekijä: Shabnam, Musharrat
Julkaistu: (2018)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
Tekijä: Paul, Pulock
Julkaistu: (2024)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
Tekijä: Bristy, Israt Zerin
Julkaistu: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
Tekijä: Khondokar, Faiza
Julkaistu: (2022)

A comprehensive review on drug repurposing in cancer treatment
Tekijä: Sarkar, Onusree
Julkaistu: (2024)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
Tekijä: Raihan, Dilraj
Julkaistu: (2024)

Lung cancer detection and classification using machine learning
Tekijä: Arefin, Mahbubul, et al.
Julkaistu: (2023)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
Tekijä: Nandy, Aditi
Julkaistu: (2022)

Recent advancement on breast cancer detection and treatment
Tekijä: Rahman, Sanjida
Julkaistu: (2023)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
Tekijä: Chakraborty, Anuradha
Julkaistu: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
Tekijä: Jahan, Nusrat
Julkaistu: (2024)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
Tekijä: Nahar, Kamrun
Julkaistu: (2023)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
Tekijä: Mukti, Roushney Fatima, et al.
Julkaistu: (2016)

Identification of the multi-drug resistant genes in the bacteria isolated from the saliva of smoker oral cancer patients and comparative analysis with smoker normal individuals
Tekijä: Hasan, Samir, et al.
Julkaistu: (2024)

Natural products and their combinatory effects in breast cancer treatment
Tekijä: Siddique, Md. Ayman
Julkaistu: (2021)

Precision medicine in four deadliest Cancers of the world : present practices & future prospects
Tekijä: Islam, Ankita
Julkaistu: (2022)

A review on the recent advancements on nanoparticles drug delivery approaches in anti-cancer treatment
Tekijä: Hoque, Syeda Mehren
Julkaistu: (2024)

Microneedles in pain management of Cancer
Tekijä: Islam, Shafiqul
Julkaistu: (2022)

Breast cancer therapy through Liposomal drug delivery system
Tekijä: Ome, Nusrat Jahan
Julkaistu: (2024)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
Tekijä: Hossain, Safa Binte
Julkaistu: (2019)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
Tekijä: Muntaha, Habibatul
Julkaistu: (2023)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Tekijä: Karim, Samia Binte
Julkaistu: (2024)

Biosimilar in lymphoma treatment
Tekijä: Tanisha, Mehrin Haque
Julkaistu: (2021)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
Tekijä: Kamal, Tasnova
Julkaistu: (2019)

A review on carbon nanotube: a new era in cancer diagnosis & therapy
Tekijä: Parvez, Safi
Julkaistu: (2023)

The impact of cell penetrating peptides in prospective cancer therapy: a review
Tekijä: Nashrah, Zannatul
Julkaistu: (2023)

Palliative care services in cancer treatment: a study of the current scenario in Dhaka
Tekijä: Rahman, Qazi Ashrafur
Julkaistu: (2018)